however, we maintain some of our concerns listed in the CY 2026 OPPS/ASC proposed rule (90 FR 33588 through 35589), including the lack of comparative data between the Axoguard HA+ Nerve Protector TM and the predicate device and other currently available treatments for the indicated condition
BPC-157 may also be appropriate for selected patients with gut irritation, inflammatory gut symptoms, gastritis-type symptoms, reflux-type irritation, or medication-related GI irritation when it is part of a broader gut-health plan
A professional may propose weekly therapy for you and monthly therapy for another patient
Advise patients that substantial or rapid weight loss can increase the risk of gallbladder disease, but that gallbladder disease may also occur in the absence of substantial or rapid weight loss
Several commenters noted that data for the individual numerator components would provide more granular insights and improve hospitals' ability to target specific areas for improvement
Among its cellular constituents, cancer-associated fibroblasts (CAFs) have emerged as pivotal regulators of TME plasticity